000			04553nam a2200541 i 4500
001			EBC3379066
003			MiAaPQ
005			20240121044049.0
006			m o d |
007			cr cnu||||||||
008			130212t20122012dcu ob 100 0 eng|d
020			_z9780309261166 (pbk.)
020			_z0309261163 (pbk.)
020			_a9780309261173 _q(electronic bk.)
035			_a(MiAaPQ)EBC3379066
035			_a(Au-PeEL)EBL3379066
035			_a(CaPaEBR)ebr10863714
035			_a(OCoLC)829421146
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRM302 _b.I58 2012
082	0		_a615.1/9 _223
110	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation, _eissuing body.
245	1	0	_aMaximizing the impact of the Cures Acceleration Network : _baccelerating the development of new drugs and diagnostics : workshop summary / _cSteve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
246	3	0	_aAccelerating the development of new drugs and diagnostics
264		1	_aWashington, District of Columbia : _bNational Academies Press, _c[2012]
264		4	_c2012
300			_a1 online resource (131 pages)
336			_atext _2rdacontent
337			_acomputer _2rdamedia
338			_aonline resource _2rdacarrier
504			_aIncludes bibliographical references (pages 71).
505	0		_aIntroduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
520			_aAdvances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
588			_aDescription based on print version record.
590			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
610	1	0	_aUnited States. _bInstitutes of Health. _bNational Center for Advancing Translational Sciences. _bCures Acceleration Network.
650		0	_aDrug monitoring.
650		0	_aDrug development _zUnited States.
650		0	_aDrugs _zUnited States _xDesign.
650		0	_aPharmaceutical industry _zUnited States _xQuality control.
655		4	_aElectronic books.
700	1		_aOlson, Steve, _d1956- _econtributor.
700	1		_aClaiborne, Anne B., _econtributor.
710	2		_aNational Institute of Medicine (U.S.). _bBoard on Health Sciences Policy, _eissuing body.
776	0	8	_iPrint version: _aInstitute of Medicine (U.S.). _tMaximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary. _dWashington, District of Columbia : National Academies Press, [2012] _hxvi, 115 pages ; 23 cm _z9780309261166 _w(OCoLC)ocn811963294 _w(DLC)10863714
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3379066 _zClick to View
999			_c206581 _d206582